Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ZIOPHARM Oncology Inc (NASDAQ:ZIOP)

6.54
Delayed Data
As of 4:00pm ET
 -0.05 / -0.76%
Today’s Change
4.45
Today|||52-Week Range
10.49
-21.30%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues800.0K800.0K1.4M4.3M
 
 
 
 
 
Depreciation And Amortization658.0K738.0K462.0K357.0K
 
 
 
 
 
 
Operating ExpensesGross Income----911.0K--
 
 
General Expenses101.3M55.3M44.4M114.1M
 
 
 
 
 
Research And Development83.4M41.8M32.7M96.8M
 
 
 
 
 
Total Operating Expenses102.0M56.0M44.9M114.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-101.2M-55.2M-43.5M-110.1M
 
 
 
 
 
Extraordinary Credit6.1M1.2M11.7M0.00
 
 
 
 
Extraordinary Charge-1.0M-1.7M0.00-10.0M
 
 
 
 
Other Expenses-13.0K-1.4M-5.0K12.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-96.1M-57.1M-31.8M-120.1M
 
 
 
 
 
Net Income-96.1M-57.1M-31.8M-120.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS78.5M85.9M101.1M125.4M
 
 
 
 
 
Shares To Calculate EPS Diluted78.5M85.9M101.1M125.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.22-$0.66-$0.31-$0.96
 
 
 
 
 
EPS Diluted-$1.22-$0.66-$0.31-$0.96